We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

hp

Advertise with Us

Latest Issue

Expo Clinical Chem.Molecular DiagnosticsHematologyImmunologyMicrobiologyPathologyTechnologyIndustry Events

Expo

Clinical Chem.Molecular DiagnosticsHematologyImmunologyMicrobiologyPathologyTechnologyIndustry Events Advertise with Us

LGC Clinical Diagnostics

Sekisui Diagnostics UK Ltd.

THE BINDING SITE

Engages in the research, development, manufacture, and distribution of immunodiagnostic assays, as wel as specialized... read more Featured Products:

Multiple Myeloma Diagnostic Test

Multiple Myeloma Diagnostic Test

Data Management Software

RID Plate Reader

Protein Analyzer

More products

DIASYS DIAGNOSTIC SYSTEMS

Download Mobile App

Video Library

more videos

Butterfly Wings-Inspired Imaging Technique Enables Faster Cancer Diagnosis

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

New Blood Test Platform Simultaneously Measures Over 100 Biomarkers of Alzheimer's Disease

Binding Site Showcases Optilite System for Special Protein Testing

By LabMedica International staff writers
Posted on 22 May 2023

Image: Optilite special protein analyzer on display at EuroMedLab Rome 2023 (Photo courtesy of Binding Site)

Image: Optilite special protein analyzer on display at EuroMedLab Rome 2023 (Photo courtesy of Binding Site)

Binding Site (Birmingham, UK) is showcasing its Optilite system, the leading solution for multiple myeloma and immune status testing, at the 2023 EuroMedLab Congress.

Optilite represents a significant breakthrough in special protein testing. The innovative system has been fully optimized to simplify complex analytical processes, delivering unparalleled efficiency, workflow optimization, and confidence in test results. With an array of intelligent features, Optilite sets a new standard in the protein laboratory field by seamlessly integrating cutting-edge technology and advanced software.

At EuroMedLab Rome 2023, Binding Site is also presenting its range of in vitro assays, which have received the CE mark for Europe, FDA clearance for the USA, and approval from regulatory authorities in multiple countries. These comprehensive assays cover all five isotypes of immunoglobulins, offering a complete solution. Among the assays being highlighted by Binding Site at the industry event are Freelite and Hevylite, which provide a comprehensive monitoring solution for managing patients with multiple myeloma.

The Freelite assay has significantly enhanced laboratory and clinical practices in the detection and follow-up of monoclonal gammopathies. The Optilite Freelite assay, FDA-cleared for aiding in the diagnosis and monitoring of multiple myeloma, represents the state-of-the-art in free light chain testing. Additionally, Hevylite is a unique immunoassay panel designed to accurately identify and quantify immunoglobulin heavy and light chain isotypes. Together, these advancements by Binding Site contribute to the advancement of diagnostic and monitoring capabilities in the field of multiple myeloma.

Related Links:
Binding Site

Visit expo >

Gold Member

Serological Pipet Controller

PIPETBOY GENIUS

New

Gold Member

Antipsychotic TDM Assays

Saladax Antipsychotic Assays

New

Automated Biochemistry Analyzer

AutoChem B861

New

Urine Analyzer

URIT-180

Latest EUROMEDLAB 2023 News

Channels

Clinical Chemistry

view channel

Image: The paper-based device generates high-quality samples of dried plasma, enabling accurate measurements of HIV viral load (Photo courtesy of Charlie Mace/Tufts)

Paper-Based Device Boosts HIV Test Accuracy from Dried Blood Samples

In regions where access to clinics for routine blood tests presents financial and logistical obstacles, HIV patients are increasingly able to collect and send a drop of blood using paper-based devices... Read more

AI-Powered Raman Spectroscopy Method Enables Rapid Drug Detection in Blood

Accurately monitoring drug levels in the blood is essential for effective treatment, particularly in the management of cardiovascular diseases. Traditional techniques for monitoring blood drug levels often... Read more

Image: The LC-MS/MS assay can serve as a reference method to validate emerging biosensors for renal function monitoring (Photo courtesy of 123RF)

Novel LC-MS/MS Assay Detects Low Creatinine in Sweat and Saliva

Timely and accurate monitoring of renal function is essential for managing patients at risk of acute kidney injury (AKI), which affects about 12% of hospitalized patients and up to 57% of ICU patients.... Read more

Biosensing Technology Breakthrough Paves Way for New Methods of Early Disease Detection

Nanopores are tiny openings that can detect individual molecules as they pass through, making them ideal for analyzing biomolecules like DNA and proteins. However, detecting proteins at extremely low ... Read more

Molecular Diagnostics

view channel

Newly Identified Stroke Biomarkers Pave Way for Blood Tests to Quickly Diagnose Brain Injuries

Each year, nearly 800,000 individuals in the U.S. experience a stroke, which occurs when blood flow to specific areas of the brain is insufficient, causing brain cells to die due to a lack of oxygen.... Read more

Image: The highly accurate test detects RNA from live fungi in blood samples and throat swabs (Photo courtesy of 123RF)

CRISPR-Based Test Diagnoses Life-Threatening Fungal Infection More Quickly

Pneumocystis jirovecii pneumonia (PJP) is a serious fungal infection that mainly affects children and those with weakened immune systems. Diagnosing PJP typically requires invasive procedures like bronchoalveolar... Read more

Image: The Anti-Measles Virus ELISA 2.0 (IgG) has received CE Mark (Photo courtesy of AdobeStock)

First Of Its Kind Measles Antibody Test Validated for Use with Dried Blood Spot Samples

Measles is a highly contagious airborne disease that can lead to serious complications for those infected. With the number of measles cases increasing worldwide, expanding and improving access to testing... Read more

Image: The simple blood test could lead to smarter, kinder treatments for childhood cancers (Photo courtesy of National Cancer Institute)

Simple Blood Test to Advance Targeted Treatments for Childhood Cancer

Researchers have developed a simple blood test that could offer deeper insights into childhood cancers, potentially leading to the development of more targeted and less toxic treatments.... Read more

Hematology

view channel

Image: The technology has the unique ability to detect challenging RhD variants that are typically excluded by other commercial tests (Photo courtesy of BillionToOne)

Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy

In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read more

Image: Leukocyte count represents an easily accessible, inexpensive clinical marker (Photo courtesy of 123RF)

WBC Count Could Predict Severity of COVID-19 Symptoms

The global health crisis caused by the SARS-CoV-2 virus continues to impact millions of people worldwide, with many experiencing persistent symptoms months after the initial diagnosis. Cognitive impairment... Read more

Image: The high precision platelet counting technology reduces risks that can lead to errors in cancer diagnoses (Photo courtesy of Adobe Stock)

New Platelet Counting Technology to Help Labs Prevent Diagnosis Errors

Accurate platelet count testing is a significant challenge for laboratories. Inaccurate results can lead to misdiagnosis, missed diagnoses, and delayed treatment for a variety of potentially fatal conditions,... Read more

Image: The study examined the diagnostic utility of ELISA testing for heparin-induced thrombocytopenia (Photo courtesy of 123RF)

Streamlined Approach to Testing for Heparin-Induced Thrombocytopenia Improves Diagnostic Accuracy

Heparin-induced thrombocytopenia (HIT), a serious side effect of the blood thinner heparin, is difficult to diagnose because thrombocytopenia, or low platelet count, can be caused by a variety of factors... Read more

Immunology

view channel

Simple Blood Test Could Help Choose Better Treatments for Patients with Recurrent Endometrial Cancer

Endometrial cancer, which develops in the lining of the uterus, is the most prevalent gynecologic cancer in the United States, affecting over 66,000 women annually. Projections indicate that in 2025, around... Read more

Novel Analytical Method Tracks Progression of Autoimmune Diseases

Patients with autoimmune diseases often have lifelong contact with doctors and hospitals. The typical patient diagnosed is a woman in her fifties and the disease requires lifelong treatment.... Read more

3D Bioprinted Gastric Cancer Model Uses Patient-Derived Tissue Fragments to Predict Drug Response

Tumor heterogeneity presents a major obstacle in the development and treatment of cancer therapies, as patients' responses to the same drug can differ, and the timing of treatment significantly influences prognosis. Consequently, technologies that predict the effectiveness of anticancer treatments are essential in minimizing... Read more

Image: The blood test for fungal infections provides faster results and has a less invasive process (Photo courtesy of 123RF)

Blood Test for Fungal Infections Could End Invasive Tissue Biopsies

For individuals with weakened immune systems, common molds found in the environment—such as in the soil, on damp walls, or on forgotten fruits—can lead to severe infections deep within the body.... Read more

Microbiology

view channel

Image: Rapid PCR testing in the ICU could not demonstrate non-inferiority in the clinical cure of pneumonia (Photo courtesy of Shutterstock)

Rapid PCR Testing in ICU Improves Antibiotic Stewardship

A collaborative study led by the University of Plymouth (Devon, UK) has shown that rapid polymerase chain reaction (PCR) testing in the intensive care unit (ICU) improved antibiotic stewardship compared... Read more

Image: The study identified a genetic signature in bacteria that, when present, indicates the likelihood of developing antibiotic resistance (Photo courtesy of Tulane University)

Unique Genetic Signature Predicts Drug Resistance in Bacteria

Antibiotic resistance represents a significant global health threat, responsible for over a million deaths each year. By 2050, the World Health Organization predicts that it could surpass cancer and heart... Read more

Unique Barcoding System Tracks Pneumonia-Causing Bacteria as They Infect Blood Stream

Bacteremia, also known as blood poisoning, occurs when bacteria manage to overcome the body's immune defenses. This condition can progress into sepsis, a serious illness that is responsible for over a... Read more

Rapid Sepsis Diagnostic Test Demonstrates Improved Patient Care and Cost Savings in Hospital Application

Sepsis is the leading cause of death and the most expensive condition treated in U.S. hospitals. The risk of death from sepsis increases by up to 8% for each hour that treatment is delayed, making early... Read more

Pathology

view channel

Image: As tumor cells flow through these microfluidic chambers, they are subjected to increasing shear stress and sorted based on their adhesion strength (Photo courtesy of UC San Diego)

Microfluidic Device Assesses Stickiness of Tumor Cells to Predict Cancer Spread

Ductal carcinoma in situ (DCIS), a type of early-stage breast cancer, is often referred to as stage zero breast cancer. In many cases, it remains harmless and does not spread beyond the milk ducts where... Read more

Image: The squares are representative partial pictures from the cancer microscopy slides, that the AI system has automatically organized by their similarity (Photo courtesy of University of Jyväskylä)

New AI Tool Outperforms Previous Methods for Identifying Colorectal Cancer from Tissue Sample Analysis

Tissue analysis typically involves a pathologist reviewing scanned digital slides from a patient’s intestinal sample and marking specific areas, such as those where cancerous and related tissues are present.... Read more

Image: Scientists have discovered the ’roadmap’ that aggressive cancer uses to spread (Photo courtesy of 123RF)

New Technique Predicts Aggressive Tumors Before They Metastasize

Tumors are held together by a structure known as the extracellular matrix (ECM), which serves as a supportive framework, similar to scaffolding around a building under construction. New research has uncovered... Read more

Butterfly Wings-Inspired Imaging Technique Enables Faster Cancer Diagnosis

Fibrosis, which refers to the accumulation of fibrous tissue, is a significant characteristic of various diseases, including neurodegenerative conditions, heart disease, and cancer. In oncology, determining... Read more

Technology

view channel

Image: Deep learning-enhanced chemiluminescence vertical flow assay for high-sensitivity cardiac Troponin I testing (Photo courtesy of Ozcan Lab/UCLA)

POC Paper-Based Sensor Platform to Transform Cardiac Diagnostics

Cardiovascular diseases continue to be the leading cause of death worldwide, accounting for over 19 million fatalities annually. Early detection of myocardial infarction (MI), commonly known as a heart... Read more

Study Explores Impact of POC Testing on Future of Diagnostics

In today’s rapidly changing world, having quick and accurate access to medical information is more crucial than ever. Point-of-Care Diagnostics (PoC-D) and Point-of-Care Testing (PoC-T) are making this... Read more

Image: The new screening device has shown promise for early lung cancer detection (Photo courtesy of Biosensors, DOI: 10.3390/bios14120624)

Low-Cost, Fast Response Sensor Enables Early and Accurate Detection of Lung Cancer

Cancer biomarkers are valuable tools for early diagnosis as their concentration in body fluids, such as serum, can be measured to detect the disease at an earlier stage. Additionally, serum levels of these... Read more

Image: The nanomaterial passively captures and preserves DNA and cells of interest from menstrual blood for testing (Photo courtesy of CELLECT)

Nanotechnology For Cervical Cancer Diagnosis Could Replace Invasive Pap Smears

Cervical cancer is the fourth most common cancer in women globally, almost always caused by the human papillomavirus (HPV), which spreads through sexual contact. The Pap test (or Pap smear) is used to... Read more

Industry

view channel

Bio-Rad to Acquire Digital PCR Developer Stilla Technologies

Bio-Rad Laboratories (Hercules, CA, USA) has entered into a binding offer to purchase all equity interests in Stilla Technologies (Villejuif, France). The acquisition remains subject to consultation with... Read more

Image: ABL and affiliates will start production and commercialization of FTD’s new UltraGene products based on PCR tests (Photo courtesy of Siemens)

ABL Signs Know-How License and Transfer Agreement for Siemens’ Fast Track Diagnostics PCR Portfolio

Advanced Biological Laboratories (ABL, Luxembourg Ville, Luxembourg) has signed a licensing and transfer agreement with Siemens Healthineers (Forchheim, Germany) for the know-how and IP rights from Fast... Read more

Becton Dickinson to Spin Out Biosciences and Diagnostic Solutions Business

Becton, Dickinson and Company (BD, Franklin Lakes, NJ, USA), has announced that its board of directors has unanimously authorized BD management to pursue a plan to separate BD's Biosciences and Diagnostic... Read more

Image: Discovery will deploy PathAI’s AISight IMS, ArtifactDetect, and TumorDetect products globally across its biospecimens business (Photo courtesy of PathAI)

New Partnership Revolutionizes Analyses of Biological Samples

PathAI (Boston, MA, USA), a leading provider of artificial intelligence (AI)-powered technology for pathology, has entered into a strategic partnership with Discovery Life Sciences (Huntsville, AL, USA),... Read more

LabMedica

About Us
Advertising Info
Subscription
Client Login
Privacy Policy
Cookie Policy
Journal Info
Contact Us

Channels

Clinical Chem.
Molecular Diagnostics
Hematology
Immunology
Microbiology
Pathology
Technology
BioResearch
Industry
Events
Focus

Features

Events Product Showcase LinkXpress Whitepapers archive Video Library

Partner Sites

LabMedica Expo HospiMedica.com Globetech.net

Archive:

BioResearch
COVID-19

2025
MEDLAB 2024
Medica ADLM Medlab 2023
Medica AACC

EUROMEDLAB Medlab 2022
MEDICA AACC ECCMID EUROMEDLAB Medlab 2021
Medica

Copyright © 2000-2025 Globetech Media. All rights reserved.

MOBILE | FULL SITE